These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6690204)

  • 21. Assessment of a 35% fluorocarbon emulsion.
    Gould SA; Sehgal LR; Rosen AL; Langdale LA; Sehgal HL; Krause L; Moss GS
    J Trauma; 1983 Aug; 23(8):720-4. PubMed ID: 6887290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of Fluosol-DA on pulmonary vessels.
    Nishimura N; Sugi T; Hiranuma N
    Prog Clin Biol Res; 1983; 122():283-9. PubMed ID: 6878371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent studies on perfluorochemical (PFC) emulsion as an oxygen carrier in Japan.
    Mitsuno T; Ohyanagi H; Yokoyama K; Suyama T
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):365-73. PubMed ID: 3052644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of fluorocarbons with and without oxygen supplementation on cardiac hemodynamics and energetics.
    Rude RE; Bush LR; Tilton GD
    Am J Cardiol; 1984 Oct; 54(7):880-3. PubMed ID: 6207721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perfluorochemical artificial blood as a volume expander in hypoxemic respiratory failure in dogs.
    Light RB; Perez-Padilla R; Kryger MH
    Chest; 1987 Mar; 91(3):444-9. PubMed ID: 3816321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of a blood substitute (Fluosol-DA, 20%) on cerebral ischemia.
    Oda Y; Handa H; Nagasawa S; Naruo Y; Asato R; Yonekawa Y
    Neurol Res; 1982; 4(1-2):35-45. PubMed ID: 6127644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluosol-DA as a red-cell substitute in acute anemia.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Langdale LA; Krause LM; Rice CL; Chamberlin WH; Moss GS
    N Engl J Med; 1986 Jun; 314(26):1653-6. PubMed ID: 3713771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial long-term effect of intracoronary perfluorochemical on infarct size and ventricular function in a canine reperfusion model.
    Forman MB; Puett DW; Wilson BH; Vaughn WK; Friesinger GC; Virmani R
    J Am Coll Cardiol; 1987 May; 9(5):1082-90. PubMed ID: 3571747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%). Part II: Human cerebral blood flow.
    Nagasawa S; Handa H; Yonekawa Y; Oda Y; Tsuda Y; Yokoyama K
    Neurol Res; 1983; 5(2):19-30. PubMed ID: 6140661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does intracoronary infusion of Fluosol-DA 20% prevent left ventricular diastolic dysfunction during coronary balloon angioplasty?
    Bell MR; Nishimura RA; Holmes DR; Bailey KR; Schwartz RS; Vlietstra RE
    J Am Coll Cardiol; 1990 Oct; 16(4):959-66. PubMed ID: 2212378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%) on cerebral circulation in the monkey.
    Nagasawa S; Handa H; Naruo Y; Oda Y; Yonekawa Y; Takebe Y
    Neurol Res; 1981; 3(3):237-50. PubMed ID: 6122175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracorporeal circulation with perfluorochemicals (Fluosol-DA).
    Hoshino S; Iwaya F; Igari T; Kanno M; Honda K
    J Cardiovasc Surg (Torino); 1982; 23(6):463-9. PubMed ID: 7153234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypotensive reaction after infusion of a perfluorochemical emulsion.
    Waxman K; Cheung CK; Mason GR
    Crit Care Med; 1984 Jul; 12(7):609-10. PubMed ID: 6610534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary complications after Fluosol administration to patients with life-threatening blood loss.
    Police AM; Waxman K; Tominaga G
    Crit Care Med; 1985 Feb; 13(2):96-8. PubMed ID: 3967511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perfluorochemical emulsion oxygen transport fluids: a clinical review.
    Tremper KK; Anderson ST
    Annu Rev Med; 1985; 36():309-13. PubMed ID: 3888055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermittent use of a perfluorochemical emulsion (Fluosol-DA 20%) and carbogen breathing with fractionated irradiation.
    Moulder JE; Fish BL
    Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1193-6. PubMed ID: 3141322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical studies of a perfluorochemical emulsion as an adjunct to radiotherapy.
    Rockwell S; Irvin CG; Kelley M
    Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):913-20. PubMed ID: 3141320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of perfluorochemical (Fluosol-DA) on infarct morphology in dogs.
    Kolodgie FD; Dawson AK; Forman MB; Virmani R
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 50(2):119-34. PubMed ID: 2868560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation.
    Teicher BA; Herman TS; Holden SA; Jones SM
    J Natl Cancer Inst; 1989 Jun; 81(12):929-34. PubMed ID: 2525198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Fluosol-DA/O2 on the antitumor activity and pulmonary toxicity of bleomycin.
    Teicher BA; Lazo JS; Merrill WW; Filderman AE; Rose CM
    Cancer Chemother Pharmacol; 1986; 18(3):213-8. PubMed ID: 2433068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.